Scientists have discovered a way to supercharge the immune system’s T cells by blocking a protein called Ant2, forcing the cells to rewire how they generate energy. This shift makes them more powerful ...

After their symptoms were dismissed, three young women of color connected online, and are now using their cancer stories to ...

Katie Couric has advocated for colon cancer awareness since her husband died of the disease in 1998. She said it's more important than ever to know your risk, as colon cancer is on the rise in young ...

A common eye-health nutrient, zeaxanthin, may also help the body fight cancer more effectively. Scientists discovered it strengthens T cells and enhances the impact of immunotherapy treatments. Found ...

Gastonia, N.C.-based CaroMont Health is investing $200 million to expand oncology services across the state. Four things to know: 1. The investment — the second largest in the system’s history — ...

“We have a long life, and we’re going to fight for it,” said Jolene Eddy Vanessa Etienne is a Staff Writer for PEOPLE on the Health team. She joined the brand in 2021. Spencer Eddy was diagnosed with ...

National cancer control plans (NCCPs) — government-led strategies that outline how a country will manage cancer care across its population — are becoming increasingly popular around the world. By ...

Revolution Medicines’ pan-RAS inhibitor helped patients with a highly aggressive form of pancreatic cancer live an average of six months longer than chemotherapy, hitting a goal of the phase 3 study.

Breast cancer is very common, with about one in eight women in the U.S. developing it over the course of their lifetime. And while most know to get regular mammograms and check for lumps, knowing the ...

Revolution Medicines said its pancreatic cancer drug daraxonrasib succeeded in a Phase 3 trial. RevMed said its drug almost doubled the typical length of survival and slashed the risk of death by 60% ...

"The Pitt" won't be making quite as big a leap between Seasons 2 and 3 as it did between Seasons 1 and 2. R. Scott Gemmill, creator of the Emmy Award-winning HBO Max medical drama, confirms to TVLine ...